Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zoetis Inc    ZTS

ZOETIS INC (ZTS)
Mes dernières consult.
Most popular
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/18/2017 09/19/2017 09/20/2017 09/21/2017 09/22/2017 Date
65.2(c) 64.78(c) 64.48(c) 64.24(c) 64.16(c) Last
1 584 970 2 005 847 2 634 685 1 232 176 1 533 243 Volume
0.00% -0.64% -0.46% -0.37% -0.12% Change
More quotes
Financials ($)
Sales 2017 5 194 M
EBIT 2017 1 774 M
Net income 2017 1 101 M
Debt 2017 3 534 M
Yield 2017 0,65%
Sales 2018 5 513 M
EBIT 2018 2 003 M
Net income 2018 1 291 M
Debt 2018 3 015 M
Yield 2018 0,72%
P/E ratio 2017 29,35
P/E ratio 2018 24,67
EV / Sales2017 6,72x
EV / Sales2018 6,24x
Capitalization 31 381 M
More Financials
Company
Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines, complemented by diagnostic products, genetic tests, bio devices and services, which are designed to meet the needs of veterinarians and the livestock farmers and companion animal.The company was... 
Sector
Pharmaceuticals
Calendar
11/07Earnings Release
More about the company
Surperformance© ratings of Zoetis Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ZOETIS INC
09/12 ZOETIS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
09/07 ZOETIS : Makes EXAME Biggest & Best in Brazil List for Third Year
09/05 ZOETIS : Announces Pricing of $1.25 Billion of Senior Notes
08/31 ANATARA LIFESCIENCES : and Zoetis to Negotiate Terms of an International Detach®..
08/31 TAKING OWNERSHIP OF YOUR CAREER DEVE : An Editorial by Roxanne Lagano
08/28 EARNINGS REVIEW AND FREE RESEARCH RE : Zoetis’ Results Beat Estimates in E..
08/28 ZOETIS INC : Earnings Review and Free Research Report: Zoetis’ Results Beat Esti..
08/24 ZOETIS : VCA Animal Hospitals and Zoetis Partner on a Successful Clinical Study ..
08/22 ZOETIS : Taurus Asset Management Continues To Keep Stake in Zoetis
08/20 ANATARA LIFESCIENCES LTD (ASX : ANR) and Zoetis to Negotiate Terms of Internatio..
More news
Sector news : Veterinary Drugs
09:44p SAP to buy customer management software firm Gigya
09/22DJCorrection to Sept. 7 Harvey Rebuilding Article
09/22 Korea tensions keep European shares in check before Germany vote
09/22 Bettencourt death stirs speculation about L'Oreal ownership
09/22 China online insurer ZhongAn prices Hong Kong IPO at top end, raises $1.5 bil..
More sector news : Veterinary Drugs
Latest Tweets
09/23Bluestein R H & Co. Purchases New Holdings in Zoetis Inc. $ZTS  
09/22Segment Wealth Management LLC Acquires Shares of 3,240 Zoetis Inc. $ZTS  
09/22ProShare Advisors LLC Sells 807 Shares of Zoetis Inc. $ZTS  
09/21Wealthfront Inc. Increases Holdings in Zoetis Inc. $ZTS  
09/21  
More tweets
Qtime:110
News from SeekingAlpha
09/21 Hold On To Zoetis In 2017
09/15 Zoetis' International Acclaim Demands Attention
09/06 Zoetis prices $1.25B debt offering
08/31 Immunovaccine announces achievement of milestones in collaboration with Zoeti..
08/24 Diagnosing Merck (Part 2 Of 2)
Chart ZOETIS INC
Duration : Period :
Zoetis Inc Technical Analysis Chart | ZTS | US98978V1035 | 4-Traders
Technical analysis trends ZOETIS INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 67,1 $
Spread / Average Target 4,6%
EPS Revisions
Managers
NameTitle
Juan Ramón Alaix President, Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Kristin C. Peck Executive Vice President & President-US Operations
Glenn David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS INC20.01%31 381
JINYU BIO-TECHNOLOGY CO LTD49.34%3 246
DECHRA PHARMACEUTICALS PLC47.96%2 502
PHIBRO ANIMAL HEALTH CORP20.65%1 412
SHANGHAI HILE BIO-TECHNOLOGY CO LTD-24.52%1 314
VIRBAC-26.44%1 243